OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic Cancer Vaccines: Current Status and Moving Forward
J Schlom
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 8, pp. 599-613
Open Access | Times Cited: 272
J Schlom
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 8, pp. 599-613
Open Access | Times Cited: 272
Showing 1-25 of 272 citing articles:
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang, Jian‐Ping Yuan, Elda Righi, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 43, pp. 17561-17566
Open Access | Times Cited: 935
Yuhui Huang, Jian‐Ping Yuan, Elda Righi, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 43, pp. 17561-17566
Open Access | Times Cited: 935
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens, Gary Middleton
Cancer Immunology Research (2015) Vol. 3, Iss. 5, pp. 436-443
Open Access | Times Cited: 728
Leisha A. Emens, Gary Middleton
Cancer Immunology Research (2015) Vol. 3, Iss. 5, pp. 436-443
Open Access | Times Cited: 728
Clinical use of dendritic cells for cancer therapy
Sébastien Anguille, Evelien Smits, Eva Lion, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 7, pp. e257-e267
Closed Access | Times Cited: 638
Sébastien Anguille, Evelien Smits, Eva Lion, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 7, pp. e257-e267
Closed Access | Times Cited: 638
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang, Shom Goel, Dan G. Duda, et al.
Cancer Research (2013) Vol. 73, Iss. 10, pp. 2943-2948
Open Access | Times Cited: 584
Yuhui Huang, Shom Goel, Dan G. Duda, et al.
Cancer Research (2013) Vol. 73, Iss. 10, pp. 2943-2948
Open Access | Times Cited: 584
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesús Prìeto, Ignacio Melero, Bruno Sangro
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 12, Iss. 12, pp. 681-700
Closed Access | Times Cited: 524
Jesús Prìeto, Ignacio Melero, Bruno Sangro
Nature Reviews Gastroenterology & Hepatology (2015) Vol. 12, Iss. 12, pp. 681-700
Closed Access | Times Cited: 524
Improving immune–vascular crosstalk for cancer immunotherapy
Yuhui Huang, Betty Y.S. Kim, Charles K. F. Chan, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 195-203
Open Access | Times Cited: 441
Yuhui Huang, Betty Y.S. Kim, Charles K. F. Chan, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 3, pp. 195-203
Open Access | Times Cited: 441
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Peter M. Moyle, István Tóth
ChemMedChem (2013) Vol. 8, Iss. 3, pp. 360-376
Closed Access | Times Cited: 428
Peter M. Moyle, István Tóth
ChemMedChem (2013) Vol. 8, Iss. 3, pp. 360-376
Closed Access | Times Cited: 428
Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment
Ruixiang Li, Yuwei He, Shuya Zhang, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 8, Iss. 1, pp. 14-22
Open Access | Times Cited: 348
Ruixiang Li, Yuwei He, Shuya Zhang, et al.
Acta Pharmaceutica Sinica B (2017) Vol. 8, Iss. 1, pp. 14-22
Open Access | Times Cited: 348
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton, Paul Silcocks, Trevor F. Cox, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 8, pp. 829-840
Open Access | Times Cited: 346
Gary Middleton, Paul Silcocks, Trevor F. Cox, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 8, pp. 829-840
Open Access | Times Cited: 346
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Alessandra Lopes, Gaëlle Vandermeulen, Véronique Préat
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 330
Alessandra Lopes, Gaëlle Vandermeulen, Véronique Préat
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 330
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu, Roshni Ravindranathan, Paweł Kaliński, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 309
Zuqiang Liu, Roshni Ravindranathan, Paweł Kaliński, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 309
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
Susan N. Thomas, Efthymia Vokali, Amanda W. Lund, et al.
Biomaterials (2013) Vol. 35, Iss. 2, pp. 814-824
Open Access | Times Cited: 278
Susan N. Thomas, Efthymia Vokali, Amanda W. Lund, et al.
Biomaterials (2013) Vol. 35, Iss. 2, pp. 814-824
Open Access | Times Cited: 278
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
Weiwei Mu, Qihui Chu, Yongjun Liu, et al.
Nano-Micro Letters (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 258
Weiwei Mu, Qihui Chu, Yongjun Liu, et al.
Nano-Micro Letters (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 258
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Combinational strategy for high-performance cancer chemotherapy
Si‐Yong Qin, Yin‐Jia Cheng, Qi Lei, et al.
Biomaterials (2018) Vol. 171, pp. 178-197
Closed Access | Times Cited: 235
Si‐Yong Qin, Yin‐Jia Cheng, Qi Lei, et al.
Biomaterials (2018) Vol. 171, pp. 178-197
Closed Access | Times Cited: 235
The immune system and inflammation in breast cancer
Xinguo Jiang, David J. Shapiro
Molecular and Cellular Endocrinology (2013) Vol. 382, Iss. 1, pp. 673-682
Open Access | Times Cited: 215
Xinguo Jiang, David J. Shapiro
Molecular and Cellular Endocrinology (2013) Vol. 382, Iss. 1, pp. 673-682
Open Access | Times Cited: 215
Immunotherapy for hepatocellular carcinoma
Zongyi Yin, Xiaowu Li
Cancer Letters (2019) Vol. 470, pp. 8-17
Closed Access | Times Cited: 215
Zongyi Yin, Xiaowu Li
Cancer Letters (2019) Vol. 470, pp. 8-17
Closed Access | Times Cited: 215
The Evolution of Poxvirus Vaccines
Lucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías‐Pérez, et al.
Viruses (2015) Vol. 7, Iss. 4, pp. 1726-1803
Open Access | Times Cited: 196
Lucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías‐Pérez, et al.
Viruses (2015) Vol. 7, Iss. 4, pp. 1726-1803
Open Access | Times Cited: 196
Recent applications of immunomodulatory biomaterials for disease immunotherapy
Huaxing Dai, Qin Fan, Chao Wang
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 194
Huaxing Dai, Qin Fan, Chao Wang
Exploration (2022) Vol. 2, Iss. 6
Open Access | Times Cited: 194
Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy
Cheng‐Hui Xu, Peng-Ju Ye, Yangchun Zhou, et al.
Acta Biomaterialia (2020) Vol. 105, pp. 1-14
Closed Access | Times Cited: 179
Cheng‐Hui Xu, Peng-Ju Ye, Yangchun Zhou, et al.
Acta Biomaterialia (2020) Vol. 105, pp. 1-14
Closed Access | Times Cited: 179
Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment
James L. Gulley, Ravi A. Madan, Russell K. Pachynski, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 109, Iss. 4
Open Access | Times Cited: 177
James L. Gulley, Ravi A. Madan, Russell K. Pachynski, et al.
JNCI Journal of the National Cancer Institute (2016) Vol. 109, Iss. 4
Open Access | Times Cited: 177
mRNA cancer vaccines: Advances, trends and challenges
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 94
Qing He, Hua Gao, Tan De-jiang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 7, pp. 2969-2989
Open Access | Times Cited: 94
Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 290-348
Closed Access | Times Cited: 46
Pratiksha Tiwari, Krishna Yadav, Ravi Prakash Shukla, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 290-348
Closed Access | Times Cited: 46
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 17
Popat Mohite, Vaishnavi Yadav, Ramdas Pandhare, et al.
ACS Omega (2024)
Open Access | Times Cited: 17
Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
Xiaosong Li, Min Min, Nan Du, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-8
Open Access | Times Cited: 192
Xiaosong Li, Min Min, Nan Du, et al.
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-8
Open Access | Times Cited: 192
